-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Sionna Therapeutics, Inc. quarterly Earnings Per Share, Diluted history and change rate from Q1 2024 to Q3 2025.
- Sionna Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending 30 Sep 2025 was -460 USD/shares, a 8013% decline year-over-year.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)